Russell Investments Group’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Russell Investments Group’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,800	Closed	-$75K	–	3005
2022 Q1	$75K	Sell	2,800 -15,751	-85%	-$529K	﹤0.01%	2599
2021 Q4	$883K	Buy	18,551 +1,500	+9%	+$67.1K	﹤0.01%	2210
2021 Q3	$1.13M	Sell	17,051 -9,110	-35%	-$649K	﹤0.01%	2137
2021 Q2	$2.04M	Buy	26,161 +2,500	+11%	+$185K	﹤0.01%	1914
2021 Q1	$2.24M	Sell	23,661 -16,816	-42%	-$2M	﹤0.01%	1818
2020 Q4	$4.93M	Buy	40,477 +14,430	+55%	+$1.58M	0.01%	1244
2020 Q3	$2.27M	Buy	26,047 +23,884	+1,104%	+$1.66M	﹤0.01%	1601
2020 Q2	$139K	Buy	+2,163	New	+$125K	﹤0.01%	2813

Other funds holding TPTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Russell Investments Group's TPTX Position: Q2 2022 in Review

Russell Investments Group sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q2 2022, closing a stake of 2,800 shares — an estimated $75K sold.

Russell Investments Group first reported a position in TPTX in Q2 2020 and held it in 8 quarters. The position peaked at $4.93M in Q4 2020. 208 funds tracked by Wall St. Rank hold TPTX as of Q2 2022.

Russell Investments Group reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Russell Investments Group sold 2,800 Turning Point Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $75K.
Russell Investments Group first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
Russell Investments Group's Turning Point Therapeutics, Inc. Common Stock position peaked at $4.93M in Q4 2020.
208 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Russell Investments Group's 13F filing for Q2 2022, filed 29 Jul 2022.